Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic landscape of transcriptional and epigenetic dysregulation in a mouse model of early onset Huntington's disease

ABSTRACT: Genomic landscape of transcriptional and epigenetic dysregulation in a mouse model of early onset Huntington's disease

PROVIDER: PRJNA192421 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR771441.fastq.gz	Fastqsanger.gz
	SRR771442.fastq.gz	Fastqsanger.gz
	SRR771443.fastq.gz	Fastqsanger.gz
	SRR771444.fastq.gz	Fastqsanger.gz
	SRR771445.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Transcriptional dysregulation in a primary cortical neuron model of Huntington's disease

Project description:Transcriptional dysregulation in a primary cortical neuron model of Huntington's disease

2018-06-09 | GSE115522 | GEO

Genomic landscape of transcriptional and epigenetic dysregulation in a mouse model of early onset Huntington's disease

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-06-20 | E-GEOD-44855 | biostudies-arrayexpress

Neurobiological Predictors of Huntington's Disease Onset (Predict-HD)

Project description:Neurobiological Predictors of Huntington's Disease Onset (Predict-HD)

| PRJNA75985 | ENA

Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease.

Project description:Transcriptional dysregulation is an important early feature of polyglutamine diseases. One of its proposed causes is defective neuronal histone acetylation, but important aspects of this hypothesis, such as the precise genomic topography of acetylation deficits and the relationship between transcriptional and acetylation alterations at the whole-genome level, remain unknown. The new techniques for the mapping of histone post-translational modifications at genomic scale enable such global analyses and are challenging some assumptions about the role of specific histone modifications in gene expression. We examined here the genome-wide correlation of histone acetylation and gene expression defects in a mouse model of early onset Huntington's disease. Our analyses identified hundreds of loci that were hypoacetylated for H3K9,14 and H4K12 in the chromatin of these mice. Surprisingly, few genes with altered transcript levels in mutant mice showed significant changes in these acetylation marks and vice versa. Our screen, however, identified a subset of genes in which H3K9,14 deacetylation and transcriptional dysregulation concur. Genes in this group were consistently affected in different brain areas, mouse models, and tissue from patients, which suggests a role in the etiology of this pathology. Overall, the combination of histone acetylation and gene expression screenings demonstrates that histone deacetylation and transcriptional dysregulation are two early, largely independent, manifestations of polyglutamine disease and suggests that additional epigenetic marks or mechanisms are required for explaining the full range of transcriptional alterations associated with this disorder.

| S-EPMC6618595 | biostudies-literature

Genomic landscape of transcriptional and epigenetic dysregulation in a mouse model of early onset Huntington's disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2013-06-20 | GSE44855 | GEO

Genomic Landscape of Diploid and Aneuploid Microsatellite Stable Early Onset Colorectal Cancer

Project description:Genomic Landscape of Diploid and Aneuploid Microsatellite Stable Early Onset Colorectal Cancer

| PRJNA1003404 | ENA

Histone deacetylation-dependent and -independent transcriptional dysregulation in early-onset polyglutamine disease

Project description:Transcriptional dysregulation is an important early feature of polyglutamine diseases. One of its proposed causes is defective neuronal histone acetylation, but important aspects of this hypothesis, such as the precise genomic topography of acetylation deficits and the relationship between transcriptional and acetylation alterations at the whole-genome level, remain unknown. The new techniques for the mapping of histone posttranslational modifications at genomic scale enable such global analyses and are challenging important assumptions concerning the role of specific histone modifications in gene expression. We examined here the genome-wide correlation of histone acetylation and gene expression defects in a mouse model of early-onset Huntington’s disease. Our analyses identified hundreds of loci that were hypoacetylated for H3K9,14 and H4K12 in the chromatin of these mice. Surprisingly, few genes with altered transcript levels in mutant mice showed significant changes in these acetylation marks and vice versa. Our screen, however, identified a subset of genes in which H3K9,14 deacetylation and transcriptional dysregulation concur. Genes in this group were consistently affected in different brain areas, mouse models and tissue from patients, which suggests a role in the etiology of this pathology. Overall, the combination of histone acetylation and gene expression screenings demonstrates that histone deacetylation and transcriptional dysregulation are two early, largely independent, manifestations of polyglutamine disease and suggests that additional epigenetic marks or mechanisms are required for explaining the full range of transcriptional alterations associated with this disorder. Examination of 2 different histone modifications in the hippocampus of wild-type and HD mice (PrP-htt-N171-82Q (Schilling et al., 1999)). Samples were obtained from 10 week old mice.

2013-06-20 | E-GEOD-44854 | biostudies-arrayexpress

Transcriptional dysregulation in a primary cortical neuron model of Huntington's disease

Project description:Transcriptional dysregulation in a primary cortical neuron model of Huntington's disease

| PRJNA475261 | ENA

Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

Project description:Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

| PRJNA779417 | ENA

Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

Project description:Shared patterns of glial transcriptional dysregulation link Huntington's disease and schizophrenia

| PRJNA779420 | ENA